In ₹ Crore except Per Share Latest Annual	ALIVUS FY24	DIVISLAB FY26	AARTIDRUGS FY26	AKUMS FY26	Peer Average
Valuation — at last close
P/E	—	99.89×	◆ 21.02×	44.45×	55.12×
P/B	—	15.28×	◆ 2.65×	3.42×	7.12×
EV/EBITDA	—	73.43×	◆ 15.09×	18.69×	35.74×
Market Cap	—	₹2.56L Cr	₹4,098 Cr	₹11,346 Cr	₹90,513 Cr
Growth
Revenue CAGR 3Y	—	◆ 10.78%	-1.89%	—	4.44%
Revenue CAGR 5Y	—	◆ 8.67%	3.55%	—	6.11%
Net Income CAGR 3Y	—	◆ 12.09%	5.43%	—	8.76%
Revenue YoY (latest Q)	—	◆ 27.80%	19.01%	13.93%	20.25%
Net Income YoY (latest Q)	—	◆ 65.50%	-7.12%	56.11%	38.16%
Profitability
EBITDA Margin	29.53%	◆ 32.59%	12.05%	11.98%	18.87% +56%
Net Income Margin	20.62%	◆ 24.32%	7.60%	5.88%	12.60% +64%
Return on Common Equity	◆ 21.07%	16.19%	13.36%	8.02%	12.52% +68%
Return on Capital Employed	◆ 26.94%	17.80%	13.34%	9.71%	13.62% +98%
Return on Assets	◆ 16.96%	13.89%	7.23%	5.36%	8.83% +92%
Credit & Quality
Total Debt/Equity	—	◆ 0.00×	0.37×	0.02×	0.13×
Interest Coverage	◆ 401.55×	129.48×	7.19×	3.91×	46.86× +757%
Scale — latest FY
Revenue / Total Income	₹2,283 Cr	₹10,560 Cr	₹2,565 Cr	₹4,359 Cr	₹5,828 Cr -61%
Net Income	₹471 Cr	₹2,568 Cr	₹195 Cr	₹256 Cr	₹1,006 Cr -53%
Total Assets	₹2,850 Cr	₹20,033 Cr	₹2,815 Cr	₹5,447 Cr	₹9,432 Cr -70%
EPS	—	₹96.75	₹21.36	₹16.67	₹44.93
Book Value per Share	—	₹632.49	₹169.7	₹216.41	₹339.53

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY24 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.